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Abstract
Coxsackie B viruses (CVBs) and echoviruses (EVs) form the Human Enterovirus-B (HEV-B) species within the family
Picornaviridae. HEV-B infections are widespread and generally cause mild disease; however, severe infections occur and
HEV-B are associated with various chronic diseases such as cardiomyopathy and type 1 diabetes. Dendritic cells (DCs) are
the professional antigen-presenting cells of our immune system and initiate and control immune responses to invading
pathogens, yet also maintain tolerance to self-antigens. We previously reported that EVs, but not CVBs, can productively
infect in vitro generated monocyte-derived DCs. The interactions between HEV-B and human myeloid DCs (mDCs) freshly
isolated from blood, however, remain unknown. Here, we studied the susceptibility and responses of BDCA1+ mDC to HEV-B
species and found that these mDC are susceptible to EV, but not CVB infection. Productive EV7 infection resulted in massive,
rapid cell death without DC activation. Contrary, EV1 infection, which resulted in lower virus input at the same MOI, resulted
in DC activation as observed by production of type I interferon-stimulated genes (ISGs), upregulation of co-stimulatory and
co-inhibitory molecules (CD80, CD86, PDL1) and production of IL-6 and TNF-a, with a relative moderate decrease in cell
viability. EV1-induced ISG expression depended on virus replication. CVB infection did not affect DC viability and resulted in
poor induction of ISGs and CD80 induction in part of the donors. These data show for the first time the interaction between
HEV-B species and BDCA1+ mDCs isolated freshly from blood. Our data indicate that different HEV-B species can influence
DC homeostasis in various ways, possibly contributing to HEV-B associated pathology.
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Introduction
Dendritic cells (DCs) are the professional antigen-presenting
cells of the immune system that are key players in initiating and
modulating innate and adaptive immune responses as well as in
maintaining tolerance. DCs express a variety of pattern recogni-
tion receptors (PRRs), such as Toll-like receptors (TLRs) and RIG-
I-like receptors (RLRs), which they use to recognize pathogens,
pathogen-associated molecules, or pathogen induced-damage
[1,2]. For example, TLR3 and the RLRs RIG-I (retinoic acid
inducible gene I) and Mda5 (melanoma differentiation- associated
gene 5) are PRRs involved in sensing double-stranded (ds) viral
RNA. Triggering of PRRs results in phenotypic maturation of the
DC and production of pro-inflammatory cytokines, enabling the
DC to initiate antiviral responses [3]. DCs (cross)present viral
peptides to CD4+ T cells and CD8+ T cells to eliminate virus
infected cells [4,5]. Viruses, however, have co-evolved with their
hosts and evade antiviral immune responses via several ways.
Some viruses, for example, are known to infect DCs directly,
interfere with their function, and thereby hamper antiviral
responses [6,7,8,9].
Members of the human enterovirus B (HEV-B) species of the
Picornaviridae family, such as coxsackie B viruses (CVB) and
echoviruses (EV) are small, non-enveloped, single-stranded RNA
viruses with a lytic life cycle. Most infections of these widespread
viruses remain limited to the gastrointestinal tract. However,
during more severe infections also secondary target organs such as
the heart, pancreas and brain may be infected, resulting in e.g.
myocarditis, pancreatitis or (meningo)encephalitis [10]. Addition-
ally, HEV-B infections have been associated with development of
autoimmune diseases such as type 1 diabetes (T1D) [11,12,13,14].
We have previously studied susceptibility and responses of in vitro
generated monocyte-derived DCs (moDCs) to HEV-B [9]. CVBs
were unable to directly infect moDC, probably due to lack of the
viral entry receptor CAR (Coxsackie- and Adenovirus Receptor)
[9]. EVs did successfully infect moDCs. One EV (EV9 Hill) was
PLOS ONE | www.plosone.org 1 April 2013 | Volume 8 | Issue 4 | e62502
studied in more detail and we reported that productive infection
with EV9 Hill did not result in DC activation (e.g. upregulation of
costimulatory molecules and pro-inflammatory cytokine produc-
tion). Instead, infection resulted in rapid loss of responsiveness to
TLR ligands and cell death. These findings suggest that EVs can
interfere with immune homeostasis via direct infection of DCs.
Our previous studies were performed with moDCs which are
in vitro differentiated from monocytes by addition of IL-4 and GM-
CSF. Due to the low frequency of naturally occurring DCs in
blood (,1% of PBMCs), many studies on DC function and
biology are performed with these moDCs. However, studying
naturally occurring myeloid DCs (mDCs) derived freshly from
blood may result in a different outcome. Naturally occurring
mDCs, have unique gene expression profiles distinct from moDC,
suggesting they can perform different functions [1,15,16,17].
Indeed differences in biological functions e.g. antigen presentation
capacity and cytokine production have been reported [18,19,20],
thus studies that investigate these naturally occurring mDCs are
warranted. Moreover, multiple studies have found enteroviral
RNA in blood and PBMCs of T1D patients, yet the source for
viral RNA as well as its role in T1D pathogenesis remains to be
established. Direct infection of blood DCs could potentially play a
role e.g. by (chronic) immune activation. Currently, no studies on
the susceptibility to, and response of, human primary blood mDCs
to HEV-B have been published, probably because of the low
frequency of these DCs in blood, which makes such studies more
challenging compared to studies with moDCs. Two subsets of
naturally occurring mDCs have been described, BDCA1+ (CD1c+)
mDCs and BDCA3+ (CD141+) mDCs [15,21,22]. Both subsets
have specialized functions that are only beginning to be unraveled,
for example they differ in their capacity to phagocytose pathogens,
produce cytokines and stimulate T cells [15,16,17,23,24]. In this
study, we set out to investigate susceptibility and responses of the
most abundant human mDC subset, BDCA1+ mDCs, freshly
isolated from blood, to HEV-B.
We show that primary BDCA1+ mDC can be efficiently
infected with various EVs, yet not by CVBs. Productive EV
infection of human BDCA1+ mDC isolated freshly from blood
results in a) induction of innate type I interferon (IFN) responses
and increased CD80 and PDL1 expression or b) rapid cell death
without apparent induction of type I IFNs or maturation,
depending on the efficiency of EV-infection. Our results demon-
strate that different HEV-B viruses have different tropism for
human BDCA1+ mDCs and that productive EV-infection has
different outcome depending on the amount of virus capable to
infect DCs. This may have significant implications for HEV-B
pathogenesis, e.g. inefficient clearance of the virus when DCs are
killed and induction of adaptive anti-viral responses is hampered.
Materials and Methods
Virus Stocks and Purification
Reference strains Echovirus 1 Farouk (EV1), EV7 Wallace
(EV7), EV8 Bryson (EV8), EV9 Hill (EV9) and EV11 Gregory
(EV11) were obtained from the National Institute for Public
Health and the Environment (RIVM, Bilthoven, The Nether-
lands). CVB3 Nancy (CVB3) and CVB4 E2 were kindly provided
by R. Kandolf (University of Tu¨bingen, Germany) and Y.W. Yoon
(University of Calgary, Canada). Production of virus stocks and
virus titrations were performed on buffalo green monkey cells as
described previously. Serial 10-fold dilutions were tested in 96-well
microtiter plates and 50% Tissue Culture Infective Doses
(TCID50) were calculated as described before [9].
Isolation, Culture and Infection of Cells
DCs were isolated from buffy coats from peripheral blood of
anonymous healthy blood donors which were obtained from
Sanquin bloodbank, Nijmegen according to institutional guide-
lines and the declaration of Helsinki. For the experiments
described herein a total of 21 buffy coats from healthy donor
were used. Myeloid BDCA1+ DCs (mDCs) were isolated using
BDCA-1 beads, using the CD1c+ DC isolation kit (Miltenyi
Biotec). Cells were routinely up to 95% pure, as assessed by double
staining for BDCA-1/CD11c (Miltenyi Biotec, and BD Pharmin-
gen, respectively). Immediately after isolation cells were used for
infection experiments. Monocyte-derived DCs (moDCs) were
generated and infected as described previously [9]. BDCA1+
mDCs were infected with indicated viruses at indicated multiplic-
ity of infection (MOI) in X-Vivo 15 (Lonza). After 1 hour
incubation at 37uC, cells were thoroughly washed and plated out
in X-Vivo supplemented with 10% FCS and 400 U/ml GM-CSF
(Strahtman). For replication experiments an input sample was
taken at t = 0, i.e. after the infection period and the washes, and at
indicated times after infection. Virus presence was determined in
cells plus supernatant combined by endpoint titration as described
above. In some experiments 50 mM rupintrivir (AG7088, a kind
gift from Pfizer) was added directly after infection. Poly I:C
(polyinosinic-polycytidylic acid) was from Enzo life sciences and
was used at 20 mg/ml.
RNA Isolation and Quantitative PCR (qPCR)
RNA isolations were done using the ZR RNA isolation kit
(Zymo Research) according to manufacturer’s instructions. RNA
was treated with DNase I (amplification grade; Invitrogen) and
reverse-transcribed into cDNA by using random hexamers and
Moloney murine leukemia virus reverse transcriptase (Invitrogen).
To exclude genomic DNA contamination we included a ‘‘2RT’’
control in which the reverse transcriptase was replaced with
RNase-free water. The ‘‘2RT’’ control was taken along in the
qPCR analysis. cDNA was stored at 220uC until further use.
mRNA levels for the genes of interest were determined by
quantitative PCR (qPCR) with a Biorad CFX apparatus (Biorad)
with SYBR Green (Applied Biosystems). Analysis was done using
Biorad CFX-1.6 software mRNA levels of the genes of interest
were normalized to mRNA levels of the housekeeping gene HPRT
(Hypoxanthine-guanine phosphoribosyltransferase) or GAPDH
(Glyceraldehyde 3-phosphate dehydrogenase) as indicated and
were calculated according to the cycle threshold method [25]. As a
cut-off for reliable PCR analysis we used 35 Ct cycles. Primer
sequences are available on request and were from the Primer Bank
database [26].
Flow Cytometry
Cells were harvested with cold PBS at indicated time points,
washed twice in PBA (PBS containing 0.5% bovine serum albumin
and 0.01% sodium azide) with 2% human serum. Cells were
incubated with conjugated cell surface markers or corresponding
isotypes for 20 minutes on ice followed by 2 washing steps in PBA.
CD55, CD80, CD86, PD-L1 were from BD Pharmingen. CD49b
(26G8 clone) was a kind gift from dr. de Fougerolles (Biogen) and
hCAR (RcmB clone) was a gift from dr. J Bergelson (University of
Pennsylvania, USA). Expression of costimulatory molecules was
analysed on CD11chigh expressing gated mDCs. For intracellular
staining cells were washed in PBS, fixed using 2% paraformalde-
hyde for 4 minutes on ice, washed in PBA and permeabilized using
0.1% saponin in PBA. Cells were subsequently blocked using
PBA/0.1% saponin/2% human serum for 30 minutes on ice
followed by incubation with the J2 double-stranded RNA antibody
Effects of Enteroviruses on Human BDCA1+ DCs
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or corresponding isotype (English & Scientific Consulting Bt.) in
PBA/0.1% saponin for 30 minutes on ice, washed, and incubated
with an Alexa-488 conjugated rabbit-anti-mouse IgG2a in PBA/
0.1% saponin for 30 minutes on ice. Viability was analyzed using
AnnexinV (BD Pharmingen) and 7-AAD (eBioscience) staining.
Cells were analysed on a CyAn Flow cytometer (Beckman Coulter)
and data was analysed using Summit software and FlowJo. Gating
strategies included exclusion of dead cells and debris in forward/
side scatter. Mean fluorescence intensity values are shown for the
entire population of DCs.
Western Blot
Western blotting was performed as described [27]. Anti-Mda5
and anti-3D polymerase antibodies were generous gifts from dr.
P.B. Fisher (Virginia Commonwealth University, School of
Medicine, Richmond, USA) and dr. C. Cameron (Pennsylvania
State University, USA), respectively, and were used in a 1:10000
and 1:1000 dilution. Quantification of intensity relative to actin
was calculated using Odyssey 2.1 software and is calculated as
(intensity protein X/intensity actin) * 1000.
ELISA
TNF-a and IL-6 production was analyzed with the human TNF
ELISA kit (BD Biosciences) and PeliPair human IL-6 Elisa
(Sanquin, Amsterdam, The Netherlands) respectively, according to
manufacturer’s instruction.
Statistical Analysis
Statistical analysis was performed using Students T-test (2 tailed
distribution) or ANOVA followed by post-hoc Tukey test, as
indicated. A p-value ,0.05 was considered a significant difference.
Results
EVs, but Not CVBs Replicate in Primary Human BDCA1+
mDCs and Induce Cell Death
To investigate the susceptibility of highly purified (.90%) blood
BDCA1+ mDCs to HEV-B, they were exposed to a series of EVs
(EV1 Farouk, EV7 Wallace, EV8 Bryson, EV9 Hill and EV11
Gregory) and CVBs (CVB3 Nancy and CVB4 E2) followed by
replication analysis. EV1, EV7, EV8, and EV11 were all able to
replicate in BDCA1+ mDCs, whereas CVB3 and CVB4 were
unable to yield infectious virus (Fig. 1A). EV9 Hill replicated in
BDCA1+ mDCs from only 50% of the donors (Fig. S1), whereas
this EV strain efficiently infects and rapidly kills moDCs (11). The
reason for this may be that the virus entry receptor for EV9 Hill is
not present on BDCA1+ mDCs isolated freshly from blood from
some donors, but is present on moDCs; however, since the
receptor used by EV9 Hill is still matter of debate (16, 18) we were
unable to determine receptor expression levels of the EV9 Hill
entry receptor. Expression of the virus entry receptor for EV7 and
EV11 (DAF, CD55) was high on mDC, whereas the EV1 and
EV8 entry receptor (VLA2, CD49b) was expressed at very low
levels (Fig. 1B). Consistent with higher DAF expression, we found
higher binding of EV7 to BDCA1+ mDCs directly after infection
(Fig. S2). Yield of infectious virus after 48 h did, however, not
differ between EV1 and EV7 infection. In BGM cells, that have
high expression of both DAF and VLA2 (data not shown) we did
not observe differences in input or virus yield (Fig. S3). Absence of
replication of CVBs can be explained by lack of the CAR receptor
on BDCA1+ mDCs, whereas CAR is readily detected on HEK
cells and BGM cells (Fig. 1B and data not shown).
Infection of BDCA1+ mDCs was confirmed by western blot
analysis. Viral 3D polymerase and its 3CD precursor were
detected in EV1- and EV7-infected BDCA1+ mDC protein
lysates, whereas this was not the case for CVB3 or mock-infection
(Fig. 1C). To confirm that indeed the BDCA1+ mDCs were the
infected cells and not contaminating other leukocytes, such as B or
T lymphocytes, we analyzed DCs by staining for the DC marker
CD11c and double-stranded RNA (dsRNA) using flowcytometry.
The J2 anti-dsRNA Ab detects dsRNA which is produced by
many RNA viruses, including enteroviruses, as an intermediate
during their replication cycle [28]. Anti-dsRNA staining of CVB-
infected BGM cells shows a good correlation with MOI (Fig. S4).
As shown in Fig. 1D dsRNA positive cells cannot be detected in
mock-infected or CVB3 infected BDCA1+/CD11chigh mDCs. In
contrast, dsRNA staining is readily detected in EV1 and EV7-
infected BDCA1+/CD11chigh mDC. We further confirmed that
there was no increase in virus titer upon infection of isolated B-
cells, which are the main contaminating cells in the BDCA1+
mDC population (Fig. S5), corroborating that virus replication
indeed occurs in the BDCA1+ myeloid DC population. Notably,
we detected higher amounts of 3D protein and dsRNA positive
cells upon EV7 infection compared to EV1 infection. Thus it
seems that EV1 less efficiently binds and/or enters the BDCA1+
mDCs and that less viral proteins and dsRNA is produced upon
EV1 infection.
Virus release upon enterovirus infection occurs via cell lysis,
thus we examined cell viability in DCs upon infection. As
expected, CVB3 infection did not result in any increased cell
death. EV1 infection resulted in a modest increase in cell death
20 h p.i. whereas upon EV7 infection rapid cell death was
observed (Fig. 1E and Fig. S6). The more pronounced cell death
upon EV7 infection correlated with higher 3D viral polymerase
expression and detection of more dsRNA positive cells compared
to EV1 (Fig. 1C and 1D). These data thus demonstrate that
CVBs cannot infect BDCA1+ mDCs isolated freshly from blood,
whereas EVs can; yet differences to induce cell death exist among
the EV stains, and correlate with the amount of virus that binds
and/or enters the cells after infection (Fig. S2).
BDCA1+ mDCs Induce Antiviral IFN-a/b Responses upon
Infection with EV1
Type I interferons (IFN-a/b) are produced and secreted upon
virus infection and induce interferon-stimulated genes (ISGs)
which encode proteins that aid in detection of viruses or function
as effector molecules important for virus elimination. The ISGs
RIG-I and Mda5 are RIG-like receptors that are involved in
recognition of a variety of RNA viruses [29,30]. One of the
effector proteins is oligo-adenylate synthetase 1 (OAS1) that
activates RNaseL which subsequently degrades RNA and prevents
further virus replication. Using qPCR we assessed whether these
ISGs were induced upon infection with HEV-B. Poly I:C (20 mg/
ml) was used as a positive control. As shown in Fig. 2A ISGs were
detected at 6 h p.i. in EV1-infected BDCA1+ mDC. This
induction was transient and after overnight incubation mRNA
expression had decreased to nearly basal levels (Fig. 2A). Western
Blot analysis 18 h p.i. revealed that EV1 also induced Mda5 and
RIG-I protein expression upon infection (Fig. 2B and Fig. S8).
In contrast to EV1, EV7 infection induced only modest ISG levels
at mRNA level (Fig. S7) and did not result in induction of ISGs at
the protein level (Fig. 2B and Fig. S8) suggesting that the rapid
induction of cell death described above prevents production of
ISGs at the protein level in EV7-infected BDCA1+ DCs. Upon
CVB3 infection ISGs were induced at mRNA level in most
donors, but interestingly, in some donors (approximately 30%) we
did not find clear induction of ISGs (i.e. induction of .5-fold
expression relative to mock-infected cells)(Fig. 2C). The reason for
Effects of Enteroviruses on Human BDCA1+ DCs
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Figure 1. Replication of human enteroviruses in primary human myeloid BDCA1+ dendritic cells. A) Freshly isolated BDCA1+ mDCs were
infected with indicated viruses at an MOI of 2 and replication was assessed at indicated time points by endpoint titration. B) Freshly isolated mDCs
were stained with indicated antibodies or corresponding isotypes and analyzed using flowcytometry. C) mDCs were infected as indicated (MOI 50)
and after 18 h infection 3D polymerase protein expression was assessed by western blot analysis. D) mDCs infected as indicated were harvested 18 h
after infection using cold PBS and amount of dsRNA was analyzed using flowcytometry. E) mDCs infected as in D) were tested for cell viability using
Annexin V/7-AAD double staining. Statistical significance was determined using ANOVA and post-hoc Tukey test. Shown are representative
experiments of more than 3 independent experiments using different donors (A–D) or average of 3 independent experiment (E) (mean values+ SEM).
* p,0.05; ** p,0.001.
doi:10.1371/journal.pone.0062502.g001
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this finding is currently unknown. In contrast, at the protein level
Mda5 induction was absent in most donors upon CVB-infection
(Fig. 2B), or induced at very low levels (data not shown).
To assess whether virus replication is required for the induction
of ISGs upon EV1 infection we analyzed ISG induction in the
presence of rupintrivir, a known inhibitor of enterovirus replica-
tion. EV1 replication was efficiently inhibited by rupintrivir
indicated by absence of virus titer increase upon infection
(Fig. 2D) and a near complete absence of 3D polymerase
(Fig. 2E) in the presence of this drug. EV1-induced expression of
Mda5 was decreased 4-fold when rupintrivir was added directly
after infection (Fig. 2E), indicating that virus replication is at least
partially required for efficient ISG induction. Induction of ISGs
was not completely abrogated, indicating that virus replication-
independent mechanisms can also induce ISGs, possibly via single-
stranded RNA present within virions that can trigger e.g. TLR7
Figure 2. ISG induction in HEV-B infected primary human myeloid BDCA1+ dendritic cells is dependent on virus replication. A)
Freshly isolated BDCA1+ mDCs were infected (EV1, MOI 50), stimulated with poly I:C (20 mg/ml) or left untreated and at indicated times RNA was
isolated and qPCR was performed as described. Statistical significance versus mock-infected cells determined by Students T-test, *P,0.05. B) mDCs
were infected with indicated viruses (MOI 50) or stimulated as for A) and after 18 h protein expression was assessed by western blot analysis. The
intensity given below the image (Mda5 Int.) represents Mda5 intensity relative to actin calculated as described in materials & methods section. C)
Freshly isolated BDCA1+ mDCs were infected (CVB3, MOI 50), stimulated with poly I:C (20 mg/ml) or left untreated and at 6 h p.i. RNA was isolated and
qPCR was performed as described. D) mDCs were infected with EV1 (MOI 50), washed in PBS and plated out. Directly after infection rupintrivir (50 mM)
(indicated as w Rupin) was added and replication was analyzed as for Fig. 1A) E) cells were infected as in D), stimulated with polyI:C (20 mg/ml) or left
unstimulated and after 20 h protein expression was analyzed by western blot. The intensity given below the image represents Mda5 or 3D intensity
relative to actin calculated as described in materials & methods section.+rupin indicates that rupintrivir was added to the DC cultures directly after
plating the cells following infection. Shown are representative experiments of 3 (B), individual donor results+average from 3 (A) or 7 (C), or
representative of 2 (D, E) independent experiments using different donors.
doi:10.1371/journal.pone.0062502.g002
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and 28, as observed for CVB3 (Fig. 2C) As expected, addition of
rupintrivir to poly I:C stimulated cells had no effect on ISG
induction (data not shown).
Full-blown BDCA1+ mDC Activation upon EV1 Infection
To investigate whether maturation is induced in BDCA1+
mDCs upon infection we determined expression levels of co-
stimulatory (CD80 and CD86) and co-inhibitory (PDL1) molecules
on their cell surface. At 18 h p.i. EV1 infection resulted in
substantial induction of CD80, CD86 and PDL1 in all donors,
relative to unstimulated or EV7 or CVB3 infected DCs (Fig. 3A).
DC activation was further confirmed by IL-6 and TNF-a secretion
upon EV1 infection (Fig. 3B). EV7-infected BDCA1+ mDCs
showed expression lower than unstimulated mDC for all markers
tested (Fig. 3A), correlating with the massive increase in cell death
observed upon EV7 infection (Fig. 1E and Fig. S6). Also at
earlier time points (e.g. 4, 8 hrs p.i.) when less cell death was
apparent in EV7-infected cells, no induction of costimulatory
molecules was observed (data not shown), probably because the
DCs haven’t had enough time to mature. Consistent with the
rapidly induced cell death, absence of costimulatory molecule
induction and absence of ISG production at the protein level, EV7
infection also did not induce pro-inflammatory cytokines (Fig. 3B).
CVB3 induced a modest, but significant increase in CD80
expression (Fig. 3A) in approximately half of the donors tested
(n = 13); yet no CD86 or PDL1 induction was observed, and pro-
inflammatory cytokines IL-6 and TNF-a were not induced upon
CVB3. Upon EV1-infection, a more pronounced upregulation of
CD80 and PDL1 is observed compared to CD86, probably caused
by relative high expression of CD86 under unstimulated condi-
tions (mock) that reaches a plateau-phase upon stimulation (EV1).
Our data indicate that EV1 infection results in full-blown
maturation of BDCA1+ mDCs isolated freshly from blood,
whereas this is not the case upon EV7 or CVB3 infection under
the conditions tested.
EV, but Not CVB Infection Impairs TLR-induced
Responses in BDCA1+ mDCs
To analyze whether infection affects the response of mDCs to
TLR ligands, they were infected with HEV-B and at 16 h p.i.
stimulated with poly I:C. After 24 h poly I:C challenge co-
stimulatory molecules and cytokine production were determined.
Poly I:C-induced expression of CD80 and PDL1 (Fig. 4A), as well
as IL-6 and TNF-a production (Fig. 4B) were not affected by
CVB3 infection. In contrast, upon EV1 infection there was no
further increase of CD80, CD86 or PDL1 expression compared to
non poly I:C-stimulated, EV1-infected cells. Poly I:C-induced IL6
and TNF production was decreased by approximately 50%
compared to mock- or CVB-infected, poly I:C-stimulated cells
(Fig. 4A and 4B), corresponding with modest induction of cell
death in BDCA1+ mDC. EV7 dramatically inhibited induction of
cell surface markers. Furthermore, hardly any IL6 or TNF-a was
induced upon poly I:C stimulation, reflecting the massive, rapid
cell death that EV7 induced in BDCA1+ mDCs. Thus, HEV-B
infection differentially affects the response of BDCA1+ mDC to
poly I:C, and this correlates with the amount of cell death induced,
suggesting that loss of viability is the main cause for lack of
responses.
BDCA1+ mDCs Respond More Rapidly and More
Pronounced to EV1 Infection Compared to in vitro
Differentiated moDCs
To relate our findings with fresh blood DCs to previous studies
with in vitro generated moDC, we compared the replication
kinetics and DC responses upon HEV-B infection. Both EV1
and EV7 replication kinetics were slower in BDCA1+ mDCs when
using the same MOI and DCs from the same donor. Virus
production increased gradually over time in BDCA1+ mDC
cultures, whereas maximal titers were reached in moDC cultures
within 12–24 hours (Fig. 1A, Fig. 5A and ref [9]), indicating
that there are differences between primary BDCA1+ mDCs and
moDCs.
CVB3 does not replicate in moDC and mDCs and no induction
of CD80 or PDL1 was observed in moDC and only a modest
CD80 induction in BDCA1+ mDCs (Fig. 5 B and C and ref [9]).
EV7 which replicates rapidly in moDC and, similar to EV7
infection of BDCA1+ mDCs, induces massive cell death, greatly
reduced CD80 expression in both DC subsets. PDL1 expression in
moDCs, however, showed a 50% decrease 18 h p.i., and only a
very modest decrease at 40 h p.i. upon EV7 infection, whereas a
nearly 100% reduction in PDL1 expression was observed in
BDCA1+ mDCs (Fig. 5B and C). Comparison between EV1-
infected moDC and BDCA1+ mDC isolated from a single donor
revealed that moDC did not increase CD80 and PDL1 after
overnight incubation, whereas this was the case for BDCA1+ mDC
(Fig. 5B). At 40 h p.i. no increase of CD80 was observed in
moDC, whereas CD80 levels further increased on BDCA1+ mDC.
PDL1 induction was induced in moDC at 48 h p.i. and
approached levels similar to those in BDCA1+ mDC 40 h p.i.
(Fig. 5C). These data indicate that naturally occurring BDCA1+
mDC are superior compared to moDC with regard to the kinetics
and the expression levels of cell surface maturation markers CD80
and PDL1 induced upon EV1 infection. In these donors, no
differences in IL6 and TNFa production were observed upon EV1
infection (data not shown), confirming previous reports that
induction of cytokines and upregulation of costimulatory mole-
cules are separate processes [31,32], since CD80 and PDL1 were
differentially induced upon EV1 infection in BDCA1+ mDCs
versus moDCs. In summary, BDCA1+ mDCs isolated freshly from
blood respond faster and more pronounced compared to in vitro
differentiated moDC with regard to CD80 and PDL1 induction
upon EV1 infection.
Discussion
We have previously characterized the response of in vitro
differentiated moDCs to different HEV-Bs [9]. In this study the
susceptibility and subsequent response of BDCA1+ mDC, which
are isolated freshly from blood and thus more physiologically
relevant compared to moDCs, to different HEV-B strains was
assessed. The data show that HEV-Bs differentially influence
human BDCA1+ mDCs function. EV7 efficiently infects and
rapidly kills the BDCA1+ mDCs and as a result does not induce
DC activation. In contrast, EV1 infection results in lower virus
input levels, lower amounts of viral proteins and dsRNA-positive
DC and modest cell death. Furthermore, EV1 infection induced
ISGs which (partially) depended on virus replication and
upregulated CD80, CD86 and PDL1. CVBs cannot productively
infect BDCA1+ mDCs, but do induce modest ISG expression and
CD80 expression. Additionally, we have shown that BDCA1+
mDCs isolated freshly from blood respond faster and more
pronounced compared to in vitro differentiated moDC with regard
to CD80 and PDL1 induction.
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Major differences in BDCA1+ mDC viability upon EV infection
were observed, with much higher cell death rates upon EV7
infection. This may relate to the expression levels of the respective
virus entry receptors. VLA2 expression was low on BDCA1+
mDCs, correlating with less viral protein expression (3D & 3CD)
and lower levels of dsRNA in EV1-infected mDCs compared to
EV7. Because VLA2 expression levels are rather low, one
possibility is that another, yet to be identified, receptor exists that
facilitates EV1 entry into human DCs. DAF was highly expressed
on mDCs, correlating with high viral protein production, high
amounts of dsRNA-positive cells and massive cell death upon
infection. Moreover, EV7 input levels were increased when
compared to EV1 when using the same MOI, indicating that
more EV7 was bound to BDCA1+ mDCs directly after infection.
When comparing EV1 and EV7 infection on BGM cells we
observed that input, replication kinetics and induction of
cytopathic effects were comparable, excluding that the differences
observed for BDCA1+ mDC are due to differences in virus titers of
the inoculums or that these differences are intrinsic to EV1 and
EV7 strains per se. This suggests that the expression levels of virus
entry receptors on BDCA1+ mDCs may be responsible for the
higher cell death induced by EV7 compared to EV1. Despite EV1
titers remaining a bit lower than those of EV7 during the entire
replication period (data not shown), at 48 hours they reach similar
values. Although indeed we did detect increased viral protein
levels (3D) on western blot and more dsRNA by flowcytometry in
EV7-infected cells, virus yield after 48 hours did not significantly
differ from that of EV1 for reasons that are currently not well
understood.
In our experiments to assess the effects on viability and function
of BDCA1+ mDCs we have used an MOI of 50 to infect the cells.
However, at lower MOIs the response of the DCs may be
different, and when less virus is present the DCs may be able to
respond more rapidly to e.g. EV7 infection by for example type I
IFN production. Our finding that EV7 virus input levels directly
after infection when using MOI 5 are comparable to the virus
input levels of EV1 using MOI 50 (data not shown) may
encompass such a scenario. Thus, the observed differences
between EV1 and EV7 with regard to viability as well as DC
maturation mainly reflect the difference in virus that is capable to
initially infect BDCA1+ mDCs. Preliminary experiments revealed
that using EV7 at lower MOI (i.e. 0.5) results in maturation of
BDCA1 mDCs – although with slower kinetics compared to EV1
at MOI 50 (data not shown). When relatively low amounts of virus
are infecting BDCA1+ mDCs, the DCs may induce an antiviral
state and thereby prevent further infection and spreading of the
virus and simultaneously induce DC maturation.
When comparing BDCA1+ mDCs isolated freshly from blood to
in vitro differentiated moDCs we found that EV9 Hill efficiently
infected moDCs from all donors tested, but that replication
occurred in BDCA1+ mDC from only 50% of the donors,
indicating that differences exist between BDCA1+ mDCs and
moDCs. EV7 infected and rapidly killed both DC subtypes,
induced no DC activation and both mDC and moDC were unable
to respond to subsequent TLR-stimulation. Upon EV1 infection
Figure 3. EV1 infection results in phenotypic maturation and production of IL6 and TNF-a. A) Freshly isolated BDCA1+ mDCs were
infected as indicated (MOI 50) and after 18 h expression of cell surface markers was determined using flowcytometry. B) Supernatant taken from
mDCs infected as in A) was analyzed for production of IL6 and TNF-a. Data shown (mean+SEM) are averages of at least 8 different experiments using
different donors. Statistical significance determined by Students T-test, * p,0.05; **p,0.01. MFI; mean fluorescence intensity.
doi:10.1371/journal.pone.0062502.g003
Effects of Enteroviruses on Human BDCA1+ DCs
PLOS ONE | www.plosone.org 7 April 2013 | Volume 8 | Issue 4 | e62502
some upregulation of PDL1 was observed in moDC at 48 h p.i.;
however, responses in BDCA1+ mDC appeared faster and much
more pronounced. VLA2 expression levels were very low on both
DC subtypes. Our data suggests that BDCA1+ mDCs may
intrinsically be better equipped to quickly respond to EV1
infection than moDC. We and others previously reported that
BDCA1+ mDCs express higher levels of TLR3 and TLR7 when
compared to moDC [23,33], but expression levels or RIG-I and
Mda5 were similar [33]. Increased expression of these TLRs
involved in sensing viral RNA may account for the more
pronounced response of BDCA1+ mDCs compared to moDC.
In vivo, additional mechanisms may affect susceptibility of cells to
viral infection, such as low constitutive expression of type I IFNs in
certain tissues, as has been described for poliovirus in mice [34].
CVB3 was not able to replicate in BDCA1+ mDCs from any of
the donors tested; consistent with our previous studies on moDCs
[9]. We cannot completely exclude that CVB infection in vivo may
occur, since CVB-strains that infect independently of CAR have
been described [35]. Additionally, CVB3 was able to infect
moDCs when entry was bypassed via electroporation of CVB3
RNA directly into the cytoplasm, and we hypothesize that a
similar scenario holds for BDCA1+ mDCs. Interestingly, in the
absence of CVB-replication, we did observe that in approximately
70% of the donors there was induction of ISGs at the mRNA level
and also CD80 was modestly upregulated in most donors. We
currently don’t know what causes these differences between
different donors upon CVB infection. However, our data indicate
that primary BDCA1+ mDCs are able to ‘‘sense’’ CVB in the
absence of measurable virus replication and subsequently respond
to the virus by modest induction of the type I IFN pathway and
CD80 expression. Recognition of viruses in the absence of virus
replication has been described before for example for HSV,
parainfluenza virus 5, Sendai virus and mumps virus [36,37]. How
BDCA1+ mDCs recognize and respond to CVB in the absence of
measurable virus replication remains to be established.
The responses of BDCA1+ mDCs from different donors varied
upon EV1 infection, with part (,60%) of the donors inducing high
levels of IL-6 and TNF-a, whereas the other donors responded
poorly or produced no pro-inflammatory cytokines at all upon
EV1 infection. The observed differences in cytokine production
upon EV1 infection may reflect the use of human blood donors
from the outbred human population [38]. Other studies have
previously reported major inter-donor differences, for example in
NK cell response [39] or with regard to Fc gamma receptor
expression levels [40], and we and others have previously
demonstrated that the response of pancreatic islets between
different human donors to CVB differs markedly [41,42].
When correlating our cytokine data to upregulation of CD80
and PDL1 we found that upregulation of CD80 and PDL1 is not
always accompanied by production of pro-inflammatory cytokines
upon EV1 infection. This suggests that induction of pro-
inflammatory cytokines and induction of co-stimulatory and co-
Figure 4. EV, but not CVB infection impairs TLR-induced responses in BDCA1+ mDCs. A) Freshly isolated BDCA1+ mDCs were infected as
indicated (MOI 50) and after 16 h all cells were stimulated with poly I:C (20 mg/ml). After an additional 24 h expression of cell surface markers was
determined using flowcytometry. Data is shown as mean fluorescent intensity minus isotype control. B) Supernatant taken from mDCs infected and
stimulated as in A) was analyzed for production of IL6 and TNF-a. Shown are averages of 2 experiments using different donors. Statistical significance
determined by Students T-test, * p,0.05. **p,0.01.
doi:10.1371/journal.pone.0062502.g004
Effects of Enteroviruses on Human BDCA1+ DCs
PLOS ONE | www.plosone.org 8 April 2013 | Volume 8 | Issue 4 | e62502
inhibitory molecules on the DC plasma membrane are differen-
tially regulated events. This is supported by studies from
Napolitani et al. and Krummen et al. who found that TLRs
potently act in synergy in the induction of IL-12 and but only
modestly cooperate in the induction of costimulatory molecules
[31,32], suggesting that cytokine induction and upregulation of
CD80 or CD86 in DCs indeed involve separate processes.
The differences observed between different HEV-B with regard
to mDC viability, activation and subsequent response to TLR
ligands may have important consequences for the immune
response against HEV-Bs in vivo. For example, rapid cell death
of mDCs may hamper induction of efficient antiviral immune
responses. Additionally, inhibition of antigen processing and MHC
class I-dependent antigen-presentation has been reported in
enterovirus-infected cells in vitro [43,44]. Murine in vivo studies
have revealed that that specific DC subsets are susceptible to CVB
infection, resulting in reduced DC number as well as impaired
capacity to prime CD8 T cells [45] underscoring the effects of
HEV-B on DCs in vivo. Additionally, reduced capacity of erythroid
and lymphoid progenitors to form colonies upon CVB infection
Figure 5. BDCA1+ mDC respond faster and more pronounced than moDC to EV1 infection. A) Freshly isolated BDCA1+ mDCs or day 6
immature moDC generated from monocytes from the same donor were infected as indicated (MOI 5) and replication was analyzed at indicated time
points. B) Freshly isolated BDCA1+ mDCs or moDCs from the same donor were infected as indicated (MOI 50) and after 18 h cell surface marker
expression was determined using flowcytometry. C) As for B) but analyzed at 40 h p.i. Shown are representative (A) or averages of 2 experiments
using different donors. Expression of surface markers in mock-infected DCs is set to 100 in all subsets for comparison. Statistical significance
determined by Students T-test, *P,0.05.
doi:10.1371/journal.pone.0062502.g005
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has been reported in mice [46]. Yet, to our knowledge no data is
available on the human in vivo situation that may differ markedly
from the murine setting due to differences in virus tropism and the
immune system in human and mice. The in vivo situation is
complex, as DCs are exposed not only to virus particles, but also to
virus-infected cells, and type I IFNs produced e.g. by HEV-B
infected cells in the gastrointestinal tract, both of which can
influence susceptibility of the DCs for infection. For example, we
have previously shown that moDCs become protected from EV-
infection when they encounter CVB-infected cells [27,47], and
speculate that this also holds true for primary mDCs. Thus the
in vivo response of myeloid DCs in blood depends not only on the
virus strain, but also on the amount of virus present and on the
interplay of the DCs with surrounding (infected) tissues. Further-
more, in vivo other DC subsets (e.g. BDCA3+ mDCs or plasma-
cytoid (p)DCs) are present which may be less susceptible to for
example EV7 infection. Additionally, cross-talk with other
immune cells, such as pDCs that can produce large quantities of
type I IFNs may prevent full-blown infection in BDCA1+ mDCs,
as we have previously shown for moDCs [33]. Yet, the fact that
different EVs can productively infect BDCA1+ blood mDCs
suggests that these viruses may interfere with immune homeostasis
in humans in vivo.
The finding that EVs are capable to infect freshly isolated
BDCA1+ mDCs from blood opens the possibility that mDCs may
serve as a reservoir for these viruses in vivo. Various studies have
reported that HEV-B RNA can be detected in blood/PBMCs of
type 1 diabetes patients [14,48], although the source for the viral
RNA remains unknown. Previous studies have shown that
monocytes can be infected by HEV-B via antibody-dependent
mechanisms [49], and more recently it has been described that
pDCs become activated by CVB in an antibody-dependent
fashion – although whether the virus also productively infects
pDC was not extensively studied [50]. Our data reveal that
myeloid DCs can be infected with EVs (in the absence of antiviral
antibodies) and thus might be an enterovirus target in vivo and
serve as a virus reservoir in blood. Whether, and how, this
contributes to enterovirus pathogenesis, and possibly also to
enterovirus-related diseases such as cardiomyopathy and type 1
diabetes remains to be established.
Supporting Information
Figure S1 Replication of EV9 Hill in 6 different donors.
BDCA1+ mDCs were infected at an MOI of 5 for 1 hour, washed
to remove unbound virus and input titers (i.e. amount of virus
present after 1 hour infection and subsequent washes that is bound
to cells or internalized in cells within the one hour infection period)
and at indicated times yield (intracellular and secreted in the
supernatant combined) was determined by endpoint titration.
Shown are 6 different donors. Black indicates donors in which
EV9 does not replicate, filled grey symbols indicate modest
replication and open grey symbols represent the donor that
showed efficient replication.
(TIF)
Figure S2 Input and yield of EV1 and EV7. BDCA1+
mDCs were infected at an MOI of 10 for 1 hour, washed to
remove unbound virus and input titers (i.e. amount of virus present
after 1 hour infection and subsequent washes that is bound to cells
or internalized in cells within the one hour infection period) and
yield (intracellular and secreted in the supernatant combined) after
48 h culture were determined by endpoint titration. Shown are
titers of 8 different donors+SEM. * p,0.05; ns, not significant.
(TIF)
Figure S3 Kinetics of EV1 and EV7 on BGM cells. BGM
cells were infected at an MOI of 10 and at indicated times
replication analysis was determined by endpoint titration.
(TIF)
Figure S4 Detection of dsRNA correlates with CVB3
infection in BGM cells. BGM cells were infected with CVB3 at
indicated MOI and after 18 h infection the amount of dsRNA was
assessed by intracellular dsRNA staining and analyzed by flow
cytometry as described. MFI: mean fluorescence intensity of
dsRNA signal.
(TIF)
Figure S5 Replication of human EV occurs in BDCA1+
mDCs and not in CD19+ B cells. Freshly isolated BDCA1+
mDC and CD19+ B-cells, which are depleted from PBMCs before
positive selection of BDCA1+ mDCs, were infected as indicated
(MOI 5) and replication was assessed by endpoint titration.
(TIF)
Figure S6 Kinetics of cell viability upon EV-infection.
mDCs were infected as in Fig. 1 and at 4, 8 and 24 hours p.i. cell
viability was analyzed by flowcytometry using A) Annexin V
(AnnV) or B) AnnV and viability dye. The percentage of AnnV (A)
or AnnV/viability dye-double positive cells (B) is shown.
(PDF)
Figure S7 Detection of ISGs at mRNA level in EV7
infected BDCA1+ mDCs. Cells were infected as in Fig. 2A and
mRNA expression of RIG-I, Mda5 and OAS1 was determined
6 h p.i. by qPCR as described.
(TIF)
Figure S8 Detection of ISGs at protein level in EV
infected BDCA1+ mDCs. Cells were treated as in Fig. 2B and
protein expression of RIG-I and Mda5 was determined by western
blotting as described.
(TIF)
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